Fig. 8From: Afrormosin exerts an anticancer effect via MAPK and AKT signaling pathways in B16F10 cellsSignaling pathway of PI3K/AKT and MAPK in B16F10 cells following treatment with afrormosin. Afrormosin modulates the MAPK signaling pathway in B16F10 cells. A After treatment of B16F10 cells with afrormosin for 2 h, phosphorylation levels of ERK and AKT decreased and phosphorylation levels of p38 and JNK increased. B Analysis of protein level by quantitation. *p < 0.05 and **p < 0.01 when compared with the control group. The data are presented as the mean ± SD; n = 3Back to article page